Jeffrey M. Leiden - 17 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Executive Chairman, Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Feb 2022
Net transactions value
-$1,914,952
Form type
4
Filing time
22 Feb 2022, 15:57:56 UTC
Previous filing
03 Feb 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,914,952 -8,236 -7.5% $232.51 102,090 17 Feb 2022 Direct
holding VRTX Common Stock 440 17 Feb 2022 401(K)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.